Back to search

Article

Thrombocytopenia and Tedizolid: A new ally in hematologic patients? Brief literature review and a clinical case

2025-10-31

Abstract excerpt

<title>Abstract</title> <p>Tedizolid (TDZ) is a second-generation oxazolidinone with potent activity against multidrug-resistant Gram-positive pathogens and a favorable hematologic safety profile compared to linezolid (LNZ). This review summarizes current evidence on TDZ pharmacokinetics, pharmacodynamics, and its reduced risk of thrombocytopenia. We also report a clinical case of a hematologic patient treated wi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f4abace5-a57a-5266-b8d2-47cd9a2daea4
DOI
10.21203/rs.3.rs-7809956/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Thrombocytopenia and Tedizolid: A new ally in hematologic patients? Brief literature review and a clinical caseDOI 10.21203/rs.3.rs-7809956/v1
Select a neighboring publication to make it the new centre.